当前位置:  首页 > 肿瘤内科 > 科室简介肿瘤内科

肿瘤内科
文章来源:湖北省肿瘤医院时间:2016-02-02

湖北省肿瘤医院内科经过40多年的发展,从单一的化疗科,发展为包括腹部肿瘤内科、胸部肿瘤内科(Ⅰ、Ⅱ病区),淋巴瘤内科和生物治疗中心的大型肿瘤学内科部门。编制病床273张,现有主任医师10人,副主任医师6人,其中博士6人,硕士20人。多人在中国抗癌协会及湖北省抗癌协会各专业委员会任委员或主任委员。在医疗、教学、科研等方面均具有雄厚的实力。

我科依据国际肿瘤学最新进展,已经完善了各种恶性肿瘤的规范化治疗,给每一个患者能够接受国际最先进、最合适和最精确的治疗。每年收治来自全国各地的肺癌、结直肠癌、胃癌、食管癌、乳腺癌、淋巴瘤等住院患者约10000人次。我科本着一切以肿瘤患者的原则,狠抓医疗质量,并定期组织多学科专家查房会诊讨论,使肿瘤患者能够获得适合自己病情的个体化规范治疗,以减少患者的痛苦,延长患者的生存时间。

淋巴瘤内科(乳腺癌、软组织肿瘤)

淋巴瘤内科(乳腺癌、软组织肿瘤)在几代医护人员经过40余年的共同的努力下,现已发展成为华中地区有一定影响力的肿瘤专科。病区现位于湖北省肿瘤医院放化疗楼的二楼,开放病床位58张。现有医生8人,其中主任医师3人,肿瘤、血液专业的硕、博士多人。同时还是中国临床肿瘤学会副主委、中国抗淋巴瘤联盟常委单位。多人在中国抗癌协会及湖北省抗癌协会各专业委员会任委员。

科室在淋巴瘤、乳腺癌、软组织肿瘤等多种恶性肿瘤治疗中有着丰富的临床经验和独特的诊疗理念。在科主任的带领下,根据国际国内的最新临床数据的指南定时更新科室的各病种的诊疗规范。在医院淋巴瘤首席专家的主持下定期开展淋巴瘤的多学科联合讨论(MDT),让每一患者能在各专科医生共同商议后得到的最为合适的诊疗方案。

多年来科室还承担了多项国际国内肿瘤新药的临床试验任务,让许多患者及早得到最新最好的治疗。

科室目前是华中地区中华慈善会及中国癌症基金会授予的肿瘤药物慈善项目指定医生的单位,每年让很多肿瘤患者在得到最新药物的治疗同时还得到了很大经费上的援助。

科室目前是共青团中央、国家卫计委授予的“青年文明号”单位。

胸部肿瘤内科一病区

病区位于放化疗大楼3楼,现正式开放床位58张,共有医护人员29名;其中,主任医师2人,副主任医师2人。

依据现代肿瘤内科的高精诊疗技术,在恶性肿瘤的诊断,化疗、内分泌治疗、生物治疗、分子靶向治疗、免疫治疗及姑息与支持治疗等方面积累了丰富的临床经验,尤其对于肺癌、食管癌、乳腺癌、胸腺癌等胸部肿瘤的综合治疗。在精准医学的时代背景下,科室积极开展了多项基因诊断技术,检测基因包括:EGFR、ALK、ROS-1、C-Met、Her-2、BRAF等,指导患者个体化靶向治疗。科室开展了大剂量化疗、新辅助化疗、术后辅助化疗、维持治疗、多途径化疗、微创腔内置管化疗等。科室注重与国际和国内先进水平接轨,开展胸部肿瘤国际和国内多中心的临床协作和临床研究,将最先进的治疗手段应用于临床。特别强调进行规范化治疗,早期整合姑息治疗,致力于 “无癌痛病房”,“无呕吐病房” 的创建,旨在为患者提供最佳的治疗方案,以最大程度提高治疗效果,降低治疗不良反应,卓有成效的改善患者生活质量,延长生存期。

本科室拥有湖北省成立最早的肿瘤专科护理团队,率先在省内开展了PICC置管术,对血管通路化学性损伤的预防和治疗,有丰富的经验;开展化疗专项护理和心灵关怀护理服务,让患者对抗肿瘤治疗有正确的认识,消除患者对治疗的恐惧心理。

胸部肿瘤内科一病区是一个团结求实、积极进取的光荣集体,全心全意为广大患者服务是我们的宗旨。

胸部肿瘤内科二病区

胸部肿瘤内科二病区是着重于肺癌、乳腺癌、食管癌等胸部肿瘤药物治疗的内科病区,结合最新的肿瘤治疗方法,为每位患者提供科学合理、规范化和个体化的综合治疗方案,以及良好的护理服务。

病区联合利用化疗、靶向治疗、生物治疗和中药治疗等肿瘤治疗手段,使肺癌的内科治疗效果达到一个新的高度,明显延长患者的生存时间。癌症疼痛是困扰患者的严重问题,严格按照WHO癌痛三阶梯止痛规范治疗癌痛患者。2012年,被卫生部授予全国第一批“癌痛规范化治疗示范病房”。

胸部肿瘤内科二病区是一个追求精诚、团结进取的团队,始终以患者满意为目标,以提高患者治疗效果、延长患者生存时间和改善患者生活质量为准则。让我们携起手来,共同战胜肿瘤!

腹部肿瘤内科病区

病区位于综合楼4楼和5楼,病床79张,现有主任医师3人,副主任医师2人,每年收治来自全国各地的结直肠癌、胃癌、肝癌、胰腺癌和腹部其他恶心肿瘤患者约3000人次,依据患者的分子特征,提供精确的个体化疗细胞毒化疗、靶向治疗或免疫治疗,以及各种治疗方法的联合,并与早期姑息治疗进行整合;定期对患者进行多学科查房讨论(MDT)。组织多次肿瘤专科培训班,积极参加省市及学会组织的恶性肿瘤防治宣传活动和省市电台及电视台的肿瘤科普讲座活动,为肿瘤的预防及早诊、早治贡献自己的力量。

生物治疗中心

而且,我们整个内科在临床诊治患者的同时,十分重视科研工作。在肺癌、结直肠癌的基础与临床研究方面处于国际领先水平。目前已获得国家及省市多项科研基金的资助。主持国家自然科学基金面上项目“肺癌DCs中β-catenin上调抑制自噬诱导CD8+T细胞耐受及其机制”、湖北省自然基金、武汉市晨光计划“肺癌DCs介导T细胞耐受的机制”及武汉市科技局重点攻关计划等10多项科研课题。

每年发表SCI论文多篇,其中包括PNAS、J Leukoc Biol等国际权威期刊。本科室医护人员近3年来在省级以上专业杂志共发表科研论文50余篇;其中SCI期刊10篇,出版专著2部;获得省市级科研成果奖各1项;参与多项GCP临床试验。


The Introduction on the Oncological Medicine Department of Hubei Cancer Hospital

After more than 40 years development, the oncological medicine department of Hubei Cancer Hospital has been established as a large medical oncology department from a single chemotherapy department, at present which includes the departments of abdominal oncology, thoracic oncology (WardⅠand Ⅱ), lymphoma oncology and biological treatment center. Our department with totally 273 beds, has 10 chief physician, and 6 associate chief physician, as well as 6 physicians with MD. and 20 physicians with Master's Degree. Many physicians are the members or chairmans in the professional committee of the Chinese Anti-Cancer Association and the Anti-Cancer Association of Hubei Province. We had vigoroso strength in cancer care, continuing education, cancer research and other aspects.

Our department based on international oncology latest developments, has perfected the standardized treatment of various malignant tumors, to provide each patient the most advanced, the most appropriate and the most accurate treatments. About 10,000 cancer cases every year from the nationwide, such as lung cancer, colorectal cancer, stomach cancer, esophageal cancer, breast cancer and lymphoma were cared. Our department in line with the patient-oriented principle performed all cancer therapies, to improve the quality of care, and especially to organize routinely multidisciplinary expert-team consultation to discuss the individual patient's condition. So cancer patients can obtain standardized treatments as soon as they came to our department, to reach their aims that are to reduce suffering and prolong survival time.

Department of Lymphoma Medicine ( Breast Cancer and Soft Tissue Tumor )

Under the joint efforts of successive  medical workers for more than 40 years, The department of Lymphoma Medicine ( Breast Cancer and Soft Tissue Tumor ) has developed into a specialized oncology department which has a certain influence in central China. The ward is located at the second floor of the Chemotherapy and Radiotherapy Building in Hubei Cancer Hospital, with 58 beds open. There are 8 doctors in the department including 3 Chief Physicians, and most of them have master’s or doctor’s degree of oncology or hematology. As a member of the standing committee  of China Anti Lymphoma Union (UCLI), one doctor in this department has been appointed as a Vice chairman of Chinese Society of Clinical Oncology (CSCO),others has the membership in many  professional committee of China anti-cancer association and Huber anti-cancer association.

The doctors in the department have extensive experience and unique clinical concept in the diagnosis and treatment of lymphoma, breast cancer, soft tissue tumors and other malignant tumors. In order to providing the most appropriate treatment to the patients, they  update treatment concepts and protocols according to the latest domestic and international guidelines, and carry out the multidisciplinary treatment (MDT) under the auspices of the chief expert of lymphoma in our hospital regularly. In addition to, they have  also been devoted to education and research of cancer science . 

The department has participated in a number of  domestic and international clinical trials about the new anticancer drugs in years to get the newest and best treatment for patients.  The department is also one of the designated doctor’s units of cancer drugs charity projects awarded by the central China Charity Federation(CCF) and the Cancer Foundation of China(CFC) ,which provide free anti-cancer drugs to low-income population. 

 The department is awarded with the "Youth Civilization Unit“ by the Central Committee of the Communist Youth League and the National Health and Family Planning Commission of China.

The First Ward of thoracic oncology 

The first Ward of thoracic oncology located in the third floor of the radio-chemotherapy Building, has now officially 58 beds. Our Ward employed a total of 29 health care workers, with 2 chief physicians, and 2 associate chief physicians.

Basis of modern high-precision medical technologies in cancer diagnosis, chemotherapy, endocrine therapy, biological therapy, molecular targeted therapy, immunotherapy and palliative and supportive care, our Ward has accumulated rich clinical experiences, especially for comprehensive treatments of thoracic solid tumors, including lung, esophagus, breast cancer and invasive thymoma. In the background of the precise medicine, our Ward had actively carried out a number of diagnostic analysis targeted to genetic driver changes, including EGFR, ALK, ROS-1, C-Met, Her-2, BRAF, etc., to guide individualized targeted therapy. The Ward also had a strong capability to administrate high-dose chemotherapy, neo-adjuvant chemotherapy, adjuvant chemotherapy, maintenance treatment, multi-channel chemotherapy and minimally invasive catheter chamber chemotherapy. The Ward has paid more attention to the international and domestic advanced levels, and carried out international and national multi-center collaboration clinical trials to research mostly types of thoracic cancer, at last in which the most advanced treatment strategies are going to be used for clinical setting. With the emphasis on standardized treatment and particularly the early integration of palliative care, we will endeavor to build a "no pain" and "no vomiting" ward, in order to provide the best treatment options for patients, to maximize the therapeutic effect and minimize treatment side effects. Our ultimate goal is to effectively improve the quality of life and prolong survival time of patients.

We have the first professional oncology nursing team in Hubei Province. PICC catheter was firstly applied in our province and routinely carried out for prevention from chemical vascular injury that was able to be relieved through our therapy with well experience. Also we conduct specially spiritual care to eliminate patient’s fear for chemotherapy, so that patients can fight against cancer with a correct understanding and a high confidence.

In a word, the Ward of thoracic oncology is a unity pragmatic and proactive collective. Our aim is to dedicate to provide precise treatments for all of patients through a concept accomplished by "patient-centered, quality-cored" services.

The Second Ward of thoracic oncology 

The second Ward of thoracic oncology is a professional setting focused on medical therapy for lung cancer, breast cancer, esophageal cancer and other thoracic cancer, to provide a scientific and rational, standardized and individualized comprehensive treatment programs for each patient.

The Ward operates a combined strategy contained of chemotherapy, targeted therapy, biological therapy and Chinese medicine, so that significantly prolonged survival time was obtained in lung cancer patients. Cancer pain had been well relieved according to the WHO analgesic ladder treatment in our Ward, although it is a severe problem plaguing the patients. Therefore, in 2012, our Ward was awarded the first batch of the demonstration unit for standardized treatment of cancer pain by China Ministry of Health. 

The Ward Ⅱ of thoracic oncology is in pursuit of a highly cooperative team. We always thought patient satisfaction is our service goal, which was achieved through activities to improve the quality of life and prolong survival time of patients. Let us join hands together to fight against cancer!

The Ward of abdominal oncology 

This Ward with 79 beds is located on the 4th and 5th floor in the compositive Building. Our Ward possessed three chief physicians and two associate chief physicians, is able to treat with about 3,000 cancer patients each year, including colorectal, stomach, liver and pancreas cancer and other abdominal tumors from different regions. We can provide individualized chemotherapy, targeted therapy, immunotherapy, and the combination with these treatment methods and integration of early palliative care, according to the molecular characteristics of the patient, by periodic multidisciplinary rounds discussion (MDT). We organized several cancer specialist training courses, and also actively participate in the provinces and the Institute of cancer prevention campaign organization, as well as tumor science lectures in radio and television for early cancer prevention, diagnosis and treatment.

As to information about the biological treatment center, you can see its website.

Moreover, the entire department of oncological medicine performed not only diagnosis and treatment of patients, but also executed a large sum of scientific research work, especially in colorectal cancer and lung cancer of basic and clinical studies at the advanced level. We had gained a number of national and provincial research funds (more than 10 research projects), supported by the National Natural Science Foundation Project, Natural Science Foundation of Hubei Province, Wuhan Morning Program and Key Research Program from Wuhan Science and Technology Bureau, such as "DCs mediated T cell tolerance mechanism in lung cancer" and "DCs increase β-catenin inhibition of autophagy induced CD8+ T cell tolerance in lung cancer"

Many SCI articles were annually published, in PNAS, J Leukoc Biol. and other international journals. In the past nearly three years we had written more than 50 articles, 10 of which were in SCI journals, and 2 professional books. We also participate in a number of GCP clinical trials. We successfully win two scientific research achievement awards from provincial and municipal government, respectively. Of course, we need to work harder to help patients stay well and get well, find cures, and fight back cancer. 


肿瘤内科
咨询电话:027-87670113

就医指南更多>>


关闭
关闭
关闭

咨询电话:027-87670138(白天) 027-87670078(午间、夜间、节假日)

医院地址:武汉市洪山区卓刀泉南路116号

邮编:430079

乘车路线:公汽596、66路终点站

552、601、590、723、715、529、538、581、901、572、586、618路(陈家湾下车前行300米)

汉口门诊部地址:硚口区中山大道91号

咨询电话:027-83802833

乘车路线:公汽2、4、411、520、808、622、708、588路居仁门站下

版权所有 湖北省肿瘤医院 鄂ICP备05008890号  

  网站建设武汉网户